Pharmacotherapy of small cell lung cancer: Current state-of-the-art
ntroduction: Lung carcinoma is the leading cause of death in men and is closely related to smoking. The article focuses on the current statistics of this pathology in the world. Materials and methods: The literature review was carried out using PubMed database and included articles published from...
Main Authors: | Tatyana A. Berezhnova, Yelena A. Lunyova, Kseniya S. Dyadina, Vladimir A. Borisov |
---|---|
Format: | Article |
Language: | English |
Published: |
Belgorod National Research University
2023-03-01
|
Series: | Research Results in Pharmacology |
Subjects: | |
Online Access: | https://rrpharmacology.ru/index.php/journal/article/view/326/344 |
Similar Items
-
Chemotherapy for small cell lung cancer: a comprehensive review
by: Syed Mustafa Karim, et al.
Published: (2012-04-01) -
Synergistic Antitumor Interaction of Risedronate Sodium and Standard Anticancer Agents in Canine (D-17) and Human Osteosarcoma (U-2 OS) Cell Lines
by: Dominik Poradowski, et al.
Published: (2022-03-01) -
Irinotecan/cisplatin versus Etoposide/cisplatin for Patients with Extensive Stage Small Cell Lung Cancer: A Systematic Review
by: Nan YAO, et al.
Published: (2009-08-01) -
A Phase III Randomized Study Comparing a Chemotherapy with Cisplatin and Etoposide to a Etoposide Regimen without Cisplatin for Patients with Extensive Small-Cell Lung Cancer
by: Thierry Berghmans, et al.
Published: (2017-09-01) -
Efficacy and safety of carboplatin and etoposide in older extensive‐stage small‐cell lung cancer patients with a poor performance status
by: Nobuaki Mamesaya, et al.
Published: (2023-03-01)